Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
FAM122A ensures cell cycle interphase progression and checkpoint control by inhibiting B55α/PP2A through helical motifs.
Wasserman JS, Faezov B, Patel KR, Kurimchak AM, Palacio SM, Glass DJ, Fowle H, McEwan BC, Xu Q, Zhao Z, Cressey L, Johnson N, Duncan JS, Kettenbach AN, Dunbrack RL Jr, Graña X. Wasserman JS, et al. Among authors: dunbrack rl jr. Nat Commun. 2024 Jul 10;15(1):5776. doi: 10.1038/s41467-024-50015-7. Nat Commun. 2024. PMID: 38982062 Free PMC article.
Correction: Exploring Co-occurring POLE Exonuclease and Non-exonuclease Domain Mutations and Their Impact on Tumor Mutagenicity.
Shah SM, Demidova EV, Ringenbach S, Faezov B, Andrake M, Gandhi A, Mur P, Viana-Errasti J, Xiu J, Swensen J, Valle L, Dunbrack RL Jr, Hall MJ, Arora S. Shah SM, et al. Among authors: dunbrack rl jr. Cancer Res Commun. 2024 May 31;4(5):1398. doi: 10.1158/2767-9764.CRC-24-0280. Cancer Res Commun. 2024. PMID: 38819318 Free PMC article. No abstract available.
Exploring Co-occurring POLE Exonuclease and Non-exonuclease Domain Mutations and Their Impact on Tumor Mutagenicity.
Shah SM, Demidova EV, Ringenbach S, Faezov B, Andrake M, Gandhi A, Mur P, Viana-Errasti J, Xiu J, Swensen J, Valle L, Dunbrack RL Jr, Hall MJ, Arora S. Shah SM, et al. Among authors: dunbrack rl jr. Cancer Res Commun. 2024 Jan 26;4(1):213-225. doi: 10.1158/2767-9764.CRC-23-0312. Epub 2024 Jan 8. Cancer Res Commun. 2024. PMID: 38282550 Free PMC article.
Corrigendum to "Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus" [Heliyon 9(4) (April 2023) e15032].
Hernandez NE, Jankowski W, Frick R, Kelow SP, Lubin JH, Simhadri V, Adolf-Bryfogle J, Khare SD, Dunbrack RL Jr, Gray JJ, Sauna ZE. Hernandez NE, et al. Among authors: dunbrack rl jr. Heliyon. 2023 Jul 6;9(8):e17901. doi: 10.1016/j.heliyon.2023.e17901. eCollection 2023 Aug. Heliyon. 2023. PMID: 37701412 Free PMC article.
Correction: Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing.
Demidova EV, Serebriiskii IG, Vlasenkova R, Kelow S, Andrake MD, Hartman TR, Kent T, Virtucio J, Rosen GL, Pomerantz RT, Dunbrack RL Jr, Golemis EA, Hall MJ, Chen DYT, Daly MB, Arora S. Demidova EV, et al. Among authors: dunbrack rl jr. BMC Genomics. 2023 Jul 10;24(1):388. doi: 10.1186/s12864-023-09486-z. BMC Genomics. 2023. PMID: 37430226 Free PMC article. No abstract available.
Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing.
Demidova EV, Serebriiskii IG, Vlasenkova R, Kelow S, Andrake MD, Hartman TR, Kent T, Virtucio J, Rosen GL, Pomerantz RT, Dunbrack RL Jr, Golemis EA, Hall MJ, Chen DYT, Daly MB, Arora S. Demidova EV, et al. Among authors: dunbrack rl jr. BMC Genomics. 2023 Apr 24;24(1):212. doi: 10.1186/s12864-023-09310-8. BMC Genomics. 2023. PMID: 37095444 Free PMC article.
Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus.
Hernandez NE, Jankowski W, Frick R, Kelow SP, Lubin JH, Simhadri V, Adolf-Bryfogle J, Khare SD, Dunbrack RL Jr, Gray JJ, Sauna ZE. Hernandez NE, et al. Among authors: dunbrack rl jr. Heliyon. 2023 Apr;9(4):e15032. doi: 10.1016/j.heliyon.2023.e15032. Epub 2023 Apr 3. Heliyon. 2023. PMID: 37035348 Free PMC article.
Correction to "The Rosetta All-Atom Energy Function for Macromolecular Modeling and Design".
Alford RF, Leaver-Fay A, Jeliazkov JR, O'Meara MJ, DiMaio FP, Park H, Shapovalov MV, Renfrew PD, Mulligan VK, Kappel K, Labonte JW, Pacella MS, Bonneau R, Bradley P, Dunbrack RL Jr, Das R, Baker D, Kuhlman B, Kortemme T, Gray JJ. Alford RF, et al. Among authors: dunbrack rl jr. J Chem Theory Comput. 2022 Jul 12;18(7):4594. doi: 10.1021/acs.jctc.2c00500. Epub 2022 Jun 6. J Chem Theory Comput. 2022. PMID: 35667008 No abstract available.
PyRosetta Jupyter Notebooks Teach Biomolecular Structure Prediction and Design.
Le KH, Adolf-Bryfogle J, Klima JC, Lyskov S, Labonte J, Bertolani S, Burman SSR, Leaver-Fay A, Weitzner B, Maguire J, Rangan R, Adrianowycz MA, Alford RF, Adal A, Nance ML, Wu Y, Willis J, Kulp DW, Das R, Dunbrack RL Jr, Schief W, Kuhlman B, Siegel JB, Gray JJ. Le KH, et al. Among authors: dunbrack rl jr. Biophysicist (Rockv). 2021 Apr;2(1):108-122. doi: 10.35459/tbp.2019.000147. Epub 2021 Apr 14. Biophysicist (Rockv). 2021. PMID: 35128343 Free PMC article.
112 results